))
Laboraverum News, 2024-01-17: Additional 49% reduction in deaths from III/IV stage of melanoma
Manage episode 400984922 series 3550131
Content provided by Eduard Kanalosh. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eduard Kanalosh or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In a phase 2b clinical trial, adding tumour’s messenger RNA to immunotherapy reduced deaths in stage III/IV melanoma by an additional 49%. These are the advanced stages of the cancer when metastases spread to several lymph nodes near the primary tumour and start to spread to distant areas of the body such as the brain, lungs, liver, etc. Patients with distant metastases have an 87% risk of death within 5 years of diagnosis. And it was at these stages that mRNA made such sensational results possible. How?
29 episodes
Share
